R Prashanth Babu: Bengaluru Fake Drug Arrest at KIA

• R Prashanth Babu, an alleged kingpin in a multi-state counterfeit medicine racket, was arrested at Bengaluru's Kempegowda International Airport.
• He was apprehended early Monday morning upon arrival from Sharjah, UAE, after a lookout notice was issued following his alleged flight to Azerbaijan.
• The racket reportedly manufactured, repackaged, and relabelled various drugs, including cancer and life-saving medicines, distributing them to over 90 Bengaluru hospitals and clinics at nearly 50 percent discounts.
• An earlier joint operation by police and Karnataka Food and Drug Administration (FDA) officials on August 18 led to the seizure of counterfeit goods and equipment worth approximately Rs 5 crore from an unlicensed facility near Bidadi.
• The ongoing investigation has so far resulted in eight arrests, including Babu and another alleged kingpin, Veeresh Kumar Jain.

This case underscores the critical vulnerability of pharmaceutical supply chains to sophisticated criminal enterprises and highlights the persistent threat posed by counterfeit pharmaceuticals to public health and the integrity of the healthcare system.

The Special Investigation Team (SIT) of the Bengaluru Police recently apprehended R Prashanth Babu, an alleged key figure in a sprawling multi-state counterfeit medicine racket, at Kempegowda International Airport (KIA). His arrest occurred early Monday morning as he arrived from Sharjah, UAE. Babu, who is a medical representative and a resident of Papareddypalya in Bengaluru, had been the subject of a lookout notice after investigators traced him to Azerbaijan, following his alleged flight from India. This significant "R Prashanth Babu Bengaluru fake drug arrest" marks a crucial development in dismantling a complex network involved in "pharmaceutical fraud Bengaluru."

Authorities allege that Babu played a central role in an illicit operation focused on the manufacture, repackaging, and relabelling of a wide array of pharmaceuticals. This included critical medications such as cancer drugs, various life-saving medicines, and even ICU injections. The sheer scope of the "Bengaluru counterfeit medicine racket" underscores the serious public health risks posed by such criminal enterprises. His apprehension at "Kempegowda International Airport arrest" highlights the concerted efforts by law enforcement to intercept individuals attempting to evade justice.

The intricate web of this "multi-state fake medicine racket India" reportedly sourced cheap, substandard generic, and expired medicines, including low-cost cancer drugs, from illegal manufacturing units located in several states, notably Telangana and Himachal Pradesh. These illicit products were then transported to an unlicensed facility situated at a farmhouse near the Bidadi toll gate in Bengaluru. Here, the medicines underwent a sophisticated repackaging process, being transferred into new vials and packages. To further deceive consumers and healthcare providers, the operation utilized forged labels, stamps, and boxes that bore the names of prominent pharmaceutical companies, making the counterfeit products appear as expensive, branded items.

The unraveling of this extensive operation began when a laborer in C K Tandya village, near Dodderi, discovered discarded pharmaceutical waste, including vials, tubes, and powder, in a field. This alert citizen promptly informed Constable Shivaraj of the Tavarekere Police Station. Acting swiftly, Constable Shivaraj visited the site in plain clothes, collected samples, and escalated the matter to senior officials. This initial tip-off led to a joint operation on August 18 involving local police and officials from the "Karnataka Food and Drug Administration (FDA) drug counterfeiting" unit. During this raid, conducted at a farmhouse in Kurubara Karenahalli near the Bidadi toll gate, authorities uncovered an unlicensed unit actively engaged in the manufacturing, repackaging, and relabelling of medicines, seizing counterfeit goods and equipment valued at approximately Rs 5 crore.

The investigation has revealed that the illicit network allegedly supplied these counterfeit pharmaceuticals to more than 90 hospitals and clinics across Bengaluru, offering them at substantial discounts of nearly 50 percent. This widespread distribution underscores the profound threat posed to patient safety and the integrity of the healthcare system. To date, the police have arrested eight individuals in connection with the case, including Babu and another alleged kingpin, Veeresh Kumar Jain, who reportedly operated the Krupa Health Care unit at Minerva Circle.

The collaborative efforts of the Bengaluru Police's Special Investigation Team and the Karnataka Food and Drug Administration (FDA) are crucial in addressing this complex "pharmaceutical fraud Bengaluru." The ongoing probe continues to delve into the multi-state dimensions of the network, aiming to identify the full extent of its sourcing and distribution channels. This case underscores the critical vulnerability of pharmaceutical supply chains to sophisticated criminal enterprises and highlights the persistent threat posed by counterfeit pharmaceuticals to public health and the integrity of the healthcare system.

This case underscores the heightened regulatory scrutiny on pharmaceutical supply chains in India, particularly in Karnataka. Lawyers and compliance officers advising pharmaceutical companies, distributors, and healthcare providers must ensure rigorous due diligence and compliance protocols are in place to prevent involvement with counterfeit medicines and mitigate severe legal and reputational risks.

Source: Based on reports from Bengaluru investigative authorities.